Computer Scan Based Analysing System on Improving Stroke Management Quality Evaluation

NCT03684629 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16570

Last updated 2022-11-23

No results posted yet for this study

Summary

Study is designed for two parts, a perspective, multi-center, historial control study and a randomized controlled study of acute ischemic stroke patients. For achieving the target of diagnosis and treatment KPI (Key performance indicator) of AIS patients and improving the defects of the traditional working mode, our center developed the medical records data acquisition and KPI statistics system based on computer scan. This method guarantees the authenticity of the data, It computes the KPI of the corresponding medical institutions in the corresponding period and gives feedback on a regular basis. Based on the KPI feedback system, a multifaceted quality improvement intervention is conducted in the intervention group hospitals. This study aims to explore whether this new working mode can continuously improve the overall KPI in Zhejiang province, and thus reflect the improvement of quality and standardization of medical service in AIS patients.

Conditions

  • Acute Ischemic Stroke and Transient Ischemic Attacks

Interventions

BEHAVIORAL

the response of KPI and corresponding suggestion

Standardized templates of medical record, evidence-based clinical pathway, and written care protocols are applied in all hospitals.The KPI of the AIS patients who were admitted to a single hospital continuously at the time of hospitalization were studied. Feedback system of performance measures: the hospital included in the study upload the medical records of all AIS patients by medical records scanning system since that month into the group. Quality control platform of Cerebral apoplexy in Zhejiang province extracts and analyze the data through the computer and calculates the corresponding monthly KPI. The hospitals will receive their own monthly KPI and the monthly highest KPI of all hospitals included in the study. Expert online consultation: based on the compare of the monthly KPI of all hospitals, Quality control platform will give corresponding suggestions to all hospitals for the improve of next month.

Sponsors & Collaborators

  • Jinhua Hospital of Zhejiang University

    collaborator UNKNOWN
  • Taizhou Hospital, Wenzhou Medical University

    collaborator UNKNOWN
  • Zhuji People's Hospital of Zhejiang Province

    collaborator OTHER
  • Huizhou Municipal Central Hospital

    collaborator OTHER
  • The Second Affiliated Hospital of Jiaxing University

    collaborator OTHER
  • Taizhou First People's Hospital

    collaborator OTHER
  • Shaoxing People's Hospital

    collaborator OTHER
  • Hangzhou Medical College

    collaborator OTHER
  • The First People's Hospital of Xiaoshan District

    collaborator UNKNOWN
  • Haining People's Hospital

    collaborator UNKNOWN
  • Shanghai Zhongshan Hospital

    collaborator OTHER
  • Lihuili Hospital of Ningbo Medical Center

    collaborator UNKNOWN
  • Tiantai People's Hospital

    collaborator UNKNOWN
  • Yuyao People's Hospital

    collaborator OTHER
  • Haiyan People's Hospital

    collaborator UNKNOWN
  • First Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER
  • Yiwu Central Hospital

    collaborator OTHER
  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Lou Min, Ph.D · The second affiliated hosipital of Zhejiang University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2020-01-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03684629 on ClinicalTrials.gov